1. Home
  2. MQ vs FTRE Comparison

MQ vs FTRE Comparison

Compare MQ & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marqeta Inc.

MQ

Marqeta Inc.

HOLD

Current Price

$4.01

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$10.20

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MQ
FTRE
Founded
2010
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MQ
FTRE
Price
$4.01
$10.20
Analyst Decision
Hold
Buy
Analyst Count
8
10
Target Price
$5.43
$15.50
AVG Volume (30 Days)
3.4M
1.6M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$588,561,000.00
$2,759,900,000.00
Revenue This Year
$25.90
$3.21
Revenue Next Year
$17.88
$0.25
P/E Ratio
N/A
N/A
Revenue Growth
20.11
1.88
52 Week Low
$3.48
$3.97
52 Week High
$7.04
$18.67

Technical Indicators

Market Signals
Indicator
MQ
FTRE
Relative Strength Index (RSI) 37.78 24.50
Support Level $3.99 $9.20
Resistance Level $4.46 $15.00
Average True Range (ATR) 0.15 1.32
MACD 0.01 -0.73
Stochastic Oscillator 20.95 13.58

Price Performance

Historical Comparison
MQ
FTRE

About MQ Marqeta Inc.

Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: